Literature DB >> 22392954

Take another CYP: confirming a novel mechanism for "idiopathic" hypercalcemia.

Thomas O Carpenter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392954      PMCID: PMC3319214          DOI: 10.1210/jc.2012-1110

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

1.  Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D.

Authors:  R St-Arnaud; A Arabian; R Travers; F Barletta; M Raval-Pandya; K Chapin; J Depovere; C Mathieu; S Christakos; M B Demay; F H Glorieux
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

2.  24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks.

Authors:  E G Seo; T A Einhorn; A W Norman
Journal:  Endocrinology       Date:  1997-09       Impact factor: 4.736

3.  Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol.

Authors:  H L Henry; A N Taylor; A W Norman
Journal:  J Nutr       Date:  1977-10       Impact factor: 4.798

4.  Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture.

Authors:  E G Seo; A W Norman
Journal:  J Bone Miner Res       Date:  1997-04       Impact factor: 6.741

5.  Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment.

Authors:  Minh Nguyen; Henri Boutignon; Eric Mallet; Agnes Linglart; Huguette Guillozo; Frederic Jehan; Michele Garabedian
Journal:  J Pediatr       Date:  2010-04-14       Impact factor: 4.406

6.  Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the Vitamin D receptor in 24(OH)ase transcription.

Authors:  Puneet Dhawan; Sylvia Christakos
Journal:  J Cell Biochem       Date:  2010-08-15       Impact factor: 4.429

7.  Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis.

Authors:  Songyang Ren; Lisa Nguyen; Shaoxing Wu; Carlos Encinas; John S Adams; Martin Hewison
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

8.  Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.

Authors:  T Sakaki; N Sawada; K Komai; S Shiozawa; S Yamada; K Yamamoto; Y Ohyama; K Inouye
Journal:  Eur J Biochem       Date:  2000-10

9.  Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.

Authors:  Sonoko Masuda; Valarie Byford; Alice Arabian; Yoshiyuki Sakai; Marie B Demay; René St-Arnaud; Glenville Jones
Journal:  Endocrinology       Date:  2004-10-21       Impact factor: 4.736

10.  Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.

Authors:  J M Canterbury; S Lerman; A J Claflin; H Henry; A Norman; E Reiss
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

View more
  3 in total

1.  1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.

Authors:  Galina Nesterova; May Christine Malicdan; Kaori Yasuda; Toshiyuki Sakaki; Thierry Vilboux; Carla Ciccone; Ronald Horst; Yan Huang; Gretchen Golas; Wendy Introne; Marjan Huizing; David Adams; Cornelius F Boerkoel; Michael T Collins; William A Gahl
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

Review 2.  The genetics of kidney stone disease and nephrocalcinosis.

Authors:  Prince Singh; Peter C Harris; David J Sas; John C Lieske
Journal:  Nat Rev Nephrol       Date:  2021-12-14       Impact factor: 28.314

Review 3.  Personalized Intervention in Monogenic Stone Formers.

Authors:  Lucas J Policastro; Subodh J Saggi; David S Goldfarb; Jeffrey P Weiss
Journal:  J Urol       Date:  2017-10-20       Impact factor: 7.450

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.